New Data Presented At UEGW Confirm Effectiveness And Safety Of RESOLOR(R) For Patients With Chronic Constipation

Data presented for the first time today at the international gastroenterology meeting UEGW (United European Gastroenterology Week) confirm the effectiveness and safety of RESOLOR(R) (prucalopride), a novel and selective, high-affinity 5-HT4 receptor agonist, for patients suffering from Chronic Constipation (CC) for whom laxatives do not provide adequate relief1. [click link for full article]

More: continued here

Filed under: GastroIntestinal / Gastroentorology on October 31st, 2007